Is PPCB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PPCB. It does not provide personalized investment advice.

PPCB (Propanc Biopharma, Inc. Common Stock) Stock Analysis - Financials

Propanc Biopharma, Inc. Common Stock (PPCB) is a publicly traded the market company. As of September 14, 2026, PPCB trades at $0.89 with a market cap of $2.10M and a P/E ratio of 0.00. PPCB moved -1.37% today. Year to date, PPCB is -93.65%; over the trailing twelve months it is -98.14%. Its 52-week range spans $0.87 to $450.00. Rallies surfaces PPCB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PPCB's key financials?

PPCB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PPCB recently traded at $0.89. Market cap is $2.10M. P/E ratio is 0.00. Revenue is $0.

PPCB Key Metrics

Key financial metrics for PPCB
Metric	Value
Price	$0.89
Market Cap	$2.10M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$450.00
52-Week Low	$0.87
Volume	218.51K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

PPCB Analyst Consensus

PPCB analyst coverage data. Average price target: $0.00.

Common questions about PPCB

What are PPCB's key financials?: PPCB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PPCB recently traded at $0.89. Market cap is $2.10M. P/E ratio is 0.00. Revenue is $0.
Is PPCB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PPCB. It does not provide personalized investment advice.